1305 York Ave2 Nd Floor Ms CenterNew York, NY 10021
Fax+1 646-962-0390
Overview of Dr. Perumal
Dr. Jai Perumal is a neurologist located in New York, NY, specializing in neuroimmunology and multiple sclerosis. She completed her medical education at Stanley Medical College and received residency and fellowship training at Detroit Medical Center/Wayne State University. She serves as an MS specialist at the Weill Cornell MS Center and New York-Presbyterian Queens and holds the position of Associate Professor at Weill Cornell Medicine. Her experience includes multiple sclerosis, healthcare outcomes research, disability evaluation, MRI. She has authored several publications in notable journals and participates in clinical trials related to multiple sclerosis. Her honors include being a Feil Clinical Scholar and receiving the Sylvia Lawry Fellowship from the National MS Society.
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Neuroimmunology & Multiple Sclerosis, 2007 - 2009- Detroit Medical Center/Wayne State UniversityResidency, Neurology, 2004 - 2007
Wayne State University School of MedicineInternship, Transitional Year, 2003 - 2004
Stanley Medical College SMCClass of 1997
Certifications & Licensure
NY State Medical License 2009 - 2026
MI State Medical License 2003 - 2012
OH State Medical License 2002 - 2003
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014, 2016-2017
- Feil Clinical Scholar Weill Cornell Medical College
Clinical Trials
- A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis Start of enrollment: 2011 Sep 20
- Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants Start of enrollment: 2012 Feb 07
- Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- B-Cell-Targeted Therapies for Black vs White Americans with Relapsing Multiple Sclerosis.Romae Hylton-Gordon, Svetlana Khanin, Yingying Xiong, Ulrike W Kaunzner, Timothy Vartanian
Ethnicity & Disease. 2025-08-01 - 3 citationsLong-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing-Remitting Multiple Sclerosis: STRIVE Data Analy...Jai Perumal, Roumen Balabanov, Laura Balcer, Steven Galetta, Zhaonan Sun
Neurology and Therapy. 2023-06-01 - 31 citationsEpsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.Yinghua Ma, David Sannino, Jennifer R Linden, Sylvia Haigh, Baohua Zhao
The Journal of Clinical Investigation. 2023-05-01
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPOHealthfirst New York
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
